Patents by Inventor W. Robert Fleischmann

W. Robert Fleischmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating diseased cells
    Publication number: 20030118549
    Abstract: Diseased cells are removed from a patient or other system, contacted with an interferon for at least 48 hours, and reintroduced into the system. In preferred methods the diseased cells are afflicted with a cancer, a bacterium, a virus or a fungus, and the interferon is an alpha interferon. The diseased cells are preferably contacted with the interferon for a relatively long period of time, such as 2, 5, 7, 10, 14 days, or even longer, and at least partially inactivated before being reintroduced.
    Type: Application
    Filed: November 15, 2002
    Publication date: June 26, 2003
    Inventor: W. Robert Fleischmann
  • Methods of treating diseased cells
    Patent number: 6432398
    Abstract: Diseased cells are removed from a patient or other system, contacted with an interferon for at least 48 hours, and reintroduced into the system. In preferred methods the diseased cells are afflicted with a cancer, a bacterium, a fungus, or a virus, and the interferon is an alpha-interferon. The diseased cells are contacted with the interferon for a relatively long period of time, such as 2, 5, 7, 14 days, or even longer, and at least partially inactivated before being reintroduced.
    Type: Grant
    Filed: March 9, 2001
    Date of Patent: August 13, 2002
    Inventor: W. Robert Fleischmann
  • Methods and compositions employing interferon-gamma
    Patent number: 5132110
    Abstract: The present invention is directed to improved pharmaceutical compositions employing interferon-gamma which have been treated to remove interferon-gamma inhibitory activity associated with such preparations. In addition, the present disclosure details treatment protocols, including the elevation of patient body temperature and the use of combined or sequential interferon-gamma treatments, to enhance interferon-gamma efficacy and reduce the resistance associated with interferon-alpha and/or beta therapy.
    Type: Grant
    Filed: May 18, 1990
    Date of Patent: July 21, 1992
    Assignee: Board of Regents, The University of Texas System
    Inventor: W. Robert Fleischmann
  • Methods and compositions employing interferon-gamma
    Patent number: 5082659
    Abstract: The present disclosure is directed to improved pharmaceutical compositions employing inteferon-gamma which have been treated to remove interferon-gamma inhibitory activity associated with such preparations. In addition, the present disclosure details treatment protocols, including the elevation of patient body temperature and the use of combined or sequential interferon-gamma treatments, to enhance inteferon-gamma efficacy and reduce the resistance associated with inteferon-alpha and/or beta therapy.
    Type: Grant
    Filed: May 23, 1990
    Date of Patent: January 21, 1992
    Assignee: Board of Regents, The University of Texas System
    Inventor: W. Robert Fleischmann
  • Methods and compositions employing interferon-gamma
    Patent number: 5030716
    Abstract: The present disclosure is directed to improved pharmaceutical compositions employing interferon-gamma which have been treated to remove interferon-gamma inhibitory activity associated with such preparations. In addition, the present disclosure details treatment protocols, including the elevation of patient body temperature and the use of combined or sequential interferon-gamma treatments, to enhance interferon-gamma efficacy and reduce the resistance associated with interferon-alpha and/or beta therapy.
    Type: Grant
    Filed: May 14, 1990
    Date of Patent: July 9, 1991
    Assignee: Board of Regents, The University of Texas System
    Inventor: W. Robert Fleischmann
  • Methods and compositions employing interferon-gamma
    Patent number: 4950470
    Abstract: The present disclosure is directed to improved pharmaceutical compositions employing interferon-gamma which have been treated to remove interferon-gamma inhibitory activity associated with such preparations. In addition, the present disclosure details treatment protocols, including the elevation of patient body temperature and the use of combined or sequential interferon-gamma treatments, to enhance interferon-gamma efficacy and reduce the resistance associated with interferon-alpha and/or beta therapy.
    Type: Grant
    Filed: October 6, 1986
    Date of Patent: August 21, 1990
    Assignee: Board of Regents, The University of Texas System
    Inventor: W. Robert Fleischmann